4082C Hosp South, Durham, NC 27710
Box 3812 Med Ctr, Durham, NC 27710
Currently, my research focuses upon the theoretical aspects of homeopathy and its clinical utilization, as well as the broader field of alternative (complementary) medicine. this is a field which has traditionally been overlooked as a legitimate scientific discipline. Other areas of activity are as in the past, i.e., clinical treatment, epidemiology, risk factors, pathogenesis of posttraumatic stress, social phobia, other anxiety status, and depression. These are illustrated by recent publications on treatment, epidemiology, health service utilization and quality of life in social phobia and PTSD, drug treatment of panic disorder. Magnetic resonance studies of social phobia have been completed and further studies are planned.
Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Non-Individualised Homeopathic Treatment.
The music of war: Seven World War 1 composers and their experience of combat.
Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Individualised Homeopathic Treatment.
Threading the needle: when embroidery was used to treat shell-shock.
Allan McLane Hamilton.
Biological aspects of post-traumatic stress disorderRead Full Text
The Wesselhoefts: A medical dynasty from the age of Goethe to the era of nuclear medicine.
Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: systematic review and meta-analysis.
Ralph Albert Blakelock (1847-1919): Psychiatric hospitalization and the abduction of an American landscape artist.
Bayard Holmes (1852-1924) and Henry Cotton (1869-1933): Surgeon-psychiatrists and their tragic quest to cure schizophrenia.
Individualized Homeopathy: A Consideration of Its Relationship to Psychotherapy.
Embracing synchronicity: Toward a new medical science of meaningful coincidenceRead Full Text
Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial.
Model validity and risk of bias in randomised placebo-controlled trials of individualised homeopathic treatment.
Pharmacotherapy of post-traumatic stress disorder: Going beyond the guidelinesRead Full Text
Richard Dadd and the Fairy Feller's Master-Stroke.
A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
Vintage treatments for PTSD: a reconsideration of tricyclic drugs.
Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis.
A Century of Homeopaths: Their Influence on Medicine and HealthRead Full Text
Examining the factor structure of the Connor-Davidson Resilience Scale (CD-RISC) in a post-9/11 U.S. military veteran sample.
The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks.
A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials.
Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder.
A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.
Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease.
A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans.Read Full Text
Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo.
REM sleep bout duration and frequency in PTSDRead Full Text
Brief social phobia scale - German version (BSPS-G)Read Full Text
PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients.
Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies.
Phobic anxiety and increased risk of mortality in coronary heart disease.
Major depressive disorder treatment guidelines in America and Europe.Read Full Text
A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD).
Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.
Major depressive disorder treatment guidelines in America and Europe.
International consensus statement on major depressive disorder.
Hubris syndrome: an acquired personality disorder? A study of US Presidents and UK Prime Ministers over the last 100 years.
Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.
First-line pharmacotherapy approaches for generalized anxiety disorderRead Full Text
Ethnic differences in the treatment of depression in patients with ischemic heart disease.
First-line pharmacotherapy approaches for generalized anxiety disorder.
A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Easing the burden of social anxiety disorder.
Treatment of post-stroke depression with antidepressants.
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
Eastern and Western spiritual beliefs and violent trauma: A U.S. national community surveyRead Full Text
Anxiety Disorders: Traumatic Stress DisordersRead Full Text
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.
The impairment of Presidents Pierce and Coolidge after traumatic bereavement.
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.
Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
Modification effects of coping on post-traumatic morbidity among earthquake rescuers.
Escitalopram in specific phobia: results of a placebo-controlled pilot trial.
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
Senator Royal Copeland. The medical and political career of a homeopathic physician.
Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome.
Treatment of obsessive-compulsive disorderRead Full Text
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.
Symptoms of neurasthenia following earthquake trauma: re-examination of a discarded syndrome.
Anxiety Disorders: New AntidepressantsRead Full Text
Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Traumatic events and posttraumatic stress in cross-cultural mission assignments.
Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies.
Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale.
The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
Neuroactive steroids are related to psychiatric symptoms in veterans returning from iraq and AfghanistanRead Full Text
A history of the concept of atypical depressionRead Full Text
A history of the concept of atypical depression.
The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
Profiling posttraumatic functional impairment.
A history of the concept of atypical depression.
Rudolf Steiner (1861-1925).
Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (vol 26, pg 373, 2006)Read Full Text
Erratum: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (Journal of Clinical Psychopharmacology (August 2006) 26, (373-378))Read Full Text
Erratum: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (Journal of Clinical Psychopharmacology (August 2006) 26, (373-378))Read Full Text
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder.
Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease.
Kava in generalized anxiety disorder: three placebo-controlled trials.
Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
Obsessive-compulsive disorder in callers to the Anxiety Disorders Association of America.
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Integrating therapies for anxiety disordersRead Full Text
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial.
Trauma and posttraumatic stress in users of the Anxiety Disorders Association of America Web site.
Mental illness in U.S. Presidents between 1776 and 1974: a review of biographical sources.
Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.
Pharmacologic treatment of acute and chronic stress following trauma: 2006.
Practical assessment and evaluation of mental health problems following a mass disaster.
The extent and impact of mental health problems after disaster.
Foreword. After the tsunami: mental health challenges to the community for today and tomorrow.
Multidimensional effects of sertraline in social anxiety disorder.
Pharmacotherapy of social anxiety disorder: what does the evidence tell us?
A comparison of the SPRINT and CAPS assessment scales for posttraumatic stress disorder.
Are the clinical effects of homoeopathy placebo effects?
Are the clinical effects of homoeopathy placebo effects?
This issue: Posttraumatic stress disorderRead Full Text
Erratum: Full and partial PTSD among earthquake survivors in rural Taiwan (Journal of Psychiatric Research (2005) 38 (313-322) DOI: 10.1016/j.jpsychires. 2003.08.005)Read Full Text
A new treatment algorithm for posttraumatic stress disorderRead Full Text
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
Antidepressant therapy in patients with ischemic heart disease.
Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
Effects of paroxetine and venlafaxine XR on heart rate variability in depression.
Levetiracetam in social phobia: a placebo controlled pilot study.
The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice.
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
Self-reported diabetes and posttraumatic stress disorder among adults in the community.
Nonpharmacologic treatments for depression in patients with coronary heart disease.
Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study.
Beliefs in karma and reincarnation among survivors of violent trauma--a community survey.
Neuroactive steroids and suicidality in posttraumatic stress disorder.
Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake.
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder.
Impact of depressive symptoms on the treatment of generalized social anxiety disorder.
Update on posttraumatic stress disorderRead Full Text
Social support and religiosity as coping strategies for anxiety in hospitalized cardiac patients.
A brief screening instrument to detect posttraumatic stress disorder in outpatient gynecology.
Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.
Post-traumatic stress after terrorist attack: psychological reactions following the US embassy bombing in Nairobi: Naturalistic study.
Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD.
Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder.
A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder.
Explanatory attributions of anxiety and recovery in a study of kava.
Suicidality as a possible side effect of antidepressant treatment.
Full and partial PTSD among earthquake survivors in rural Taiwan.
New Challenges for Anxiety Disorders: Where Treatment, Resilience, and Economic Priority ConvergeRead Full Text
Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder.
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.
Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale.
A 43-year-old woman with symptoms of PTSDRead Full Text
Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
Posttraumatic stress disorder: acquisition, recognition, course, and treatment.
Suicidality as a Possible Side Effect of Antidepressant Treatment.
Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder.
Long-term treatment and prevention of posttraumatic stress disorder.
Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety.
Panel discussion: changing how we think about insomnia.
Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression.
Posttraumatic stress disorder in callers to the Anxiety Disorders Association of America.
Social anxiety disorder in callers to the Anxiety Disorders Association of America.
Spirituality, resilience, and anger in survivors of violent trauma: a community survey.
Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies.
Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.
Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences.
Posttraumatic distress and coping strategies among rescue workers after an earthquake.
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
Effectiveness of chromium in atypical depression: a placebo-controlled trial.
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
Treatment of posttraumatic stress disorder: the impact of paroxetine.
Pharmacotherapy of social phobia.
Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC).
Study refusal and exclusion from a randomized treatment study of generalized social phobia.
Hyperhidrosis in social anxiety disorder.
Efficacy of olanzapine in social anxiety disorder: a pilot study.
Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
Surviving disaster: what comes after the trauma?
Sertraline maintenance treatment reduced relapse and dropouts in post-traumatic stress disorderRead Full Text
Botanical medicines for anxiety: do they have a place?
St John's wort and depression.
A placebo-controlled study of Kava kava in generalized anxiety disorder.
Characterizing the effects of sertraline in post-traumatic stress disorder.
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
Homeopathic constitutional type questionnaire correlates of conventional psychological and physical health scales: individual difference characteristics of young adults.
Homeopathic pathogenetic trials and the constitutional type questionnaire.
Tolerability of fluoxetine in posttraumatic stress disorder.
The impact of borderline personality disorder on post-traumatic stress in the community: a study of health status, health utilization, and functioning.
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder.
Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials.
Impact of generalized social anxiety disorder in managed care.
Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
St. John's wort in generalized anxiety disorder: three case reports.
Symptomatic and functional assessment of social anxiety disorder in adults.
Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings.
Insight and treatment outcome in obsessive-compulsive disorder.
Adverse-effect profile of kava.
The self-assessment of resilience and anxiety: psychometric properties.
Evaluating medicinal herbs.
Social anxiety disorder in review: two decades of progress.
SPRINT: a brief global assessment of post-traumatic stress disorder.
Recognition and treatment of posttraumatic stress disorder.
Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.
The Constitutional Type Questionnaire: validation in the patient population of the Royal London Homoeopathic Hospital.
Do constitutional types really exist? A further study using grade of membership analysis.
Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
Generalized anxiety disorder. An important clinical concern.
Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction.
A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care.
Predictors of treatment response in patients with posttraumatic stress disorder.
Advances and emerging treatments in social phobiaRead Full Text
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients.
Mini-SPIN: A brief screening assessment for generalized social anxiety disorder.
Pharmacotherapy of generalized anxiety disorder.
What is generalized anxiety disorder?
Consensus statement on depression, anxiety, and oncology.
Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment.
Clinician-administered PTSD scale: a review of the first ten years of research.
Neurobiological mechanisms in generalized anxiety disorder.
Consensus statement on depression, anxiety, and functional gastrointestinal disorders.
Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety.
Consensus statement on depression, anxiety, and cardiovascular disease.
Generalized anxiety disorder: nature and course.
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.
Completeness of response and quality of life in mood and anxiety disordersRead Full Text
Further discussion of EMDR for treatment of PTSD.
EMDR for treatment of PTSD.
Psychodynamic psychotherapy for PTSD.
Omission of bupropion as a recommended treatment for PTSD.
Post traumatic stress disorder: Guidelines for investigating efficacy of pharmacological interventionRead Full Text
Defining an appropriate management strategy for social anxiety disorder.
Symptom-specific effects of fluoxetine in post-traumatic stress disorder.
Trauma: The impact of post-traumatic stress disorderRead Full Text
Social anxiety disorder under scrutinyRead Full Text
Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans.
Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.
Ambulatory cardiovascular activity in Vietnam combat veterans with and without posttraumatic stress disorder.
Selective serotonin reuptake inhibitors in post-traumatic stress disorder.
New strategies for the treatment of posttraumatic stress disorderRead Full Text
Completeness of response and quality of life in mood and anxiety disorders.
Trauma: the impact of post-traumatic stress disorder.
Social anxiety disorder under scrutiny.
Posttraumatic stress disorder: epidemiology and health-related considerations.
Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.
Alternative therapy use by psychiatric outpatients.
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
Functional impairment and utilization of services associated with posttraumatic stress in the community.
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Treatment of social phobia with gabapentin: a placebo-controlled study.
The economic burden of anxiety disorders in the 1990s.
Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study.
A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder.
Demographics, treatment seeking, and diagnoses of anxiety support group participants.
Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine.
Nefazodone in post-traumatic stress disorder: results from six open-label trials.
Treatment of posttraumatic stress disorderRead Full Text
A pilot study of mirtazapine in post-traumatic stress disorder.
Consensus criteria for traumatic grief. A preliminary empirical test.
Social phobia: issues in assessment and management.
Management of posttraumatic stress disorder: diagnostic and therapeutic issues.
Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD.
The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?
Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety.
Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives.
The constitution: Views from homoeopathy and psychiatryRead Full Text
Discontinuation of clonazepam in the treatment of social phobia.
Homeopathic and psychiatric perspectives on grief.
Open trial of nefazodone for combat-related posttraumatic stress disorder.
A family study of chronic post-traumatic stress disorder following rape trauma.
Treatment of posttraumatic stress disorder with nefazodone.
Fluvoxamine in civilians with posttraumatic stress disorder.
A Consensus Meeting on Effective Research Practice in PTSDRead Full Text
The Role of Serotonin in Posttraumatic Stress Disorder: Neurobiology and PharmacotherapyRead Full Text
Focus on social anxiety disorder: IntroductionRead Full Text
Social anxiey disorder: Etiology and early clinical presentation: CommentsRead Full Text
How is recovery from social anxiety disorder defined?: CommentsRead Full Text
The nature of social anxiety disorder: CommentsRead Full Text
Brain mechanisms of social anxiety disorder: CommentsRead Full Text
Psychotherapy in the overall management strategy for social anxiety disorder: CommentsRead Full Text
Psychiatric disorders in primary care patients receiving complementary medical treatments.
Pharmacotherapy of social anxiety disorder.
The long-term treatment of panic disorder.
Bupropion sustained release: a therapeutic overview.
Pivotal studies of clonazepam in panic disorder.
Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety.
The efficacy of new pharmacological treatments for panic disorder: evaluating the trials.
Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety.
Panic disorder and social phobia: current treatments and new strategies.
Adjunctive use of olanzapine in mood disorders: five case reports.
Post-traumatic stress disorder: what's in a name?
Response characteristics to antidepressants and placebo in post-traumatic stress disorder.
Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans.
A repeat proton magnetic resonance spectroscopy study in social phobia.
Explained and unexplained medical symptoms in generalized anxiety and panic disorder: relationship to the somatoform disorders.
Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder.
Moclobemide in social phobia: a controlled dose-response trial.
The effects of clonazepam on quality of life and work productivity in panic disorder.
Familial risk factors in posttraumatic stress disorder.
Screening for trauma history on an inpatient affective-disorders unit: a pilot study.
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
Panic disorder: making clinical sense of the latest research.
The undertreatment of dysthymia.
Images in psychiatryRead Full Text
The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder.
Homeopathic treatment of depression and anxiety.
Assessment of a new self-rating scale for post-traumatic stress disorder.
The Brief Social Phobia Scale: a psychometric evaluation.
Repairing the shattered self: recovering from trauma.
Biological therapies for posttraumatic stress disorder: an overview.
Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria.
Use of benzodiazepines in panic disorder.
Trauma: prevalence, impairment, service use, and cost.
Functional status in depressed patients: the relationship to disease severity and disease resolution.
A 2-year follow-up of social phobia. Status after a brief medication trial.
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design.
The neurobiology of social phobia.
The association of sexual assault and attempted suicide within the community.
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.
Validation of the Davidson Trauma Scale in a sample of survivors of childhood sexual abuse.
Quality of life and cost factors in panic disorderRead Full Text
A multi-modal treatment for incest survivors: Preliminary outcome dataRead Full Text
Quality of life and cost factors in panic disorder.
Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia.
Meeting of minds in psychiatry and homeopathy: an example in social phobia.
Proving methodologyRead Full Text
Multivariate analysis of five homoeopathic medicines in a psychiatric populationRead Full Text
Biological characterization of social phobia.
Algorithm for the treatment of panic disorder with agoraphobia.
The boundary of social phobia. Exploring the threshold.
Social phobia: outlook for the '90s.
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
Bupropion in chronic low back pain.
Adinazolam sustained-release treatment of panic disorder: a double-blind study.
Treatment of social phobia with benzodiazepines.
Pharmacotherapy for post-traumatic stress disorder.
Magnetic resonance imaging in social phobia.
International advances in the treatment of social phobia.
Sexual dysfunction and antidepressantsRead Full Text
Psychiatry and homoeopathy. Basis for a dialogueRead Full Text
Introduction. Social phobia in review: 1993Read Full Text
Post-traumatic stress disorder.
Magnetic resonance spectroscopy in social phobia: preliminary findings.
Treatment of social phobia with clonazepam and placebo.
The role of nuclear magnetic resonance imaging in psychiatric research.
The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study.
Predicting response to amitriptyline in posttraumatic stress disorder.
Biology of social phobiaRead Full Text
Social phobia: biological aspects and pharmacotherapy.
ErratumRead Full Text
Drug therapy of post-traumatic stress disorder.
Erratum: Predictors of response to monoamine oxidase inhibitors: Do they exist? (Eur Arch Psychiatry Clin Neurosci (1992) 241: 181-186)Read Full Text
Levels of urinary free cortisol in social phobia.
The Brief Social Phobia Scale.
A 102-center prospective study of seizure in association with bupropion.
Long-term treatment of social phobia with clonazepam.
Diagnostic issues in posttraumatic stress disorder: considerations for the DSM-IV.
Post-traumatic stress disorder in the community: an epidemiological study.
Fluoxetine in post-traumatic stress disorderRead Full Text
Refining criteria for posttraumatic stress disorder.
Diagnostic Issues in Posttraumatic Stress Disorder: Considerations for the DSM-IVRead Full Text
Social phobia in reviewRead Full Text
Predictors of response to monoamine oxidase inhibitors: do they exist?
Continuation treatment of panic disorder with high-potency benzodiazepines.
Traumatic experiences in psychiatric outpatientsRead Full Text
Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder.
Treatment of posttraumatic stress disorder with amitriptyline and placebo.
New perspectives on anxiety disorders in DSM-IV and ICD-10Read Full Text
Posttraumatic stress disorder: Recent advances in basic science and clinical researchRead Full Text
Measuring results of treatment of PTSD.
Classification of depression by grade of membership: a confirmation study.
Symptoms of interpersonal sensitivity in depression.
The corticotropin-releasing hormone test in patients with posttraumatic stress disorder.
Seizures and bupropion: a review.
Familial psychiatric illness in chronic posttraumatic stress disorder.
Validity and reliability of the DSM-III criteria for posttraumatic stress disorder. Experience with a structured interview.
Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions.
Tribulin in post-traumatic stress disorder.
The response of depressed inpatients to isocarboxazid.
A comparative evaluation of three discriminant scales for endogenous depression.
An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology.
A study of depressive typologies using grade of membership analysis.
The DST and posttraumatic stress disorder.
Diagnostic utility of the dexamethasone suppression test.
An outpatient evaluation of phenelzine and imipramine.
A pilot study of phenelzine in the treatment of post-traumatic stress disorder.
Personality in chronic post-traumatic stress disorder:. A study of the eysenck inventoryRead Full Text
Preliminary study of carbamazepine in post-traumatic stress disorder.
The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants.
The effects of isocarboxazid on blood pressure and pulse.
The Montgomery-Asberg Depression Scale: reliability and validity.
An assessment of the Newcastle Anxiety Depression Index.
Diagnostic significance of vegetative symptoms in depression.
Forms of atypical depression and their response to antidepressant drugs.
ResponseRead Full Text
Effects of stimulus parameters on cognitive side effects.
Effects of electroconvulsive therapy upon brain electrical activity.
Platelet MAO activity in posttraumatic stress disorder.
Neurovegetative symptoms in chronic pain and depression.
What does the dexamethasone suppression test identify?
Chronic pain and depression. I. Classification of depression in chronic low back pain patients.
Chronic pain and depression. II. Symptoms of anxiety in chronic low back pain patients and their relationship to subtypes of depression.
Monoamine oxidase inhibitors in patients with chronic pain.
A follow-up study of post partum illness, 1946-1978.
Neuroticism and personality disorder in depression.
BW234: A nondopamine receptor‐blocking antipsychotic drug without extrapyramidal side effects?Read Full Text
A diagnostic and family study of posttraumatic stress disorder.
Validation of four definitions of melancholia by the dexamethasone suppression test.
Patient compliance with MAO inhibitor therapy.
Practical aspects of MAO inhibitor therapy.
The importance of dose in isocarboxazid therapy.
The dexamethasone suppression test in borderline personality disorder.
MAO inhibitor therapy in trichotillomania associated with depression: case report.
Comparative diagnostic criteria for melancholia and endogenous depression.
An evaluation of two doses of isocarboxazid in depression.
The Newcastle Endogenous Depression Diagnostic Index: validity and reliability.
Urinary excretion of biopterin and neopterin in psychiatric disorders.
Depressive illness and placebo responseRead Full Text
Classification of depressive disorders: A multiaxial approachRead Full Text
Use of phenelzine in continuation therapy.
Deep-vein thrombosis with antipsychotic drugs.
Characteristics of schizophrenic and depressed patients excluded from clinical research.
The effect of isocarboxazid on platelet MAO activity.
A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
Isocarboxazid. Efficacy and tolerance.
Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.
Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms.
Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobiasRead Full Text
Failure of isocarboxazid and haloperidol to alleviate delusional depression in a pilot study.
The first clinical study of BW-234U in schizophrenia.
Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid.
Adding a tricyclic antidepressant to a monoamine oxidase inhibitor.
Early and late side effects of phenelzine.
Evaluation of the central nervous system risks of ECTRead Full Text
A comparison of phenelzine and imipramine in depressed inpatients.
Biological and/or genetic factors in alcoholism.
MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study.
Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Platelet monoamine oxidase activity and the classification of depression.
Platelet gamma-aminobutyrate-alpha-ketoglutarate transaminase (GABA-T) in schizophrenia.
A comparison of inpatients with primary unipolar depression and depression secondary to anxiety.
Catechol-O-methyltransferase activity and classification of depression.
Single case study. Complementary effects of phenelzine and psychotherapy in long term treatment of depression.
Platelet MAO inhibition following tricyclic antidepressant therapy.
A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression.
Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
Antidepressant drug therapy in psychotic depression.
Platelet monoamine oxidase activity in schizophrenia.
Red blood cell catechol O-methyl transferase and response to imipramine in unipolar depressive women.
Catechol O-methyltransferase in red blood cells of schizophrenic, depressed, and normal human subjects.
Inpatient and outpatient patterns of psychotropic drug prescribing by nonpsychiatrist physicians.
Psychotropic drugs on general medical and surgical wards of a teaching hospital.
Nicotinic acid and schizophrenia: a critiqueRead Full Text
The management of resistant depression.
Post-partum mood change in Jamaican women: a description and discussion on its significance.
Ketamine ("Ketalar"): a safer anaesthetic for ECT.
Psychosis and ketamine.
Psychosis and ketamine.